Literature DB >> 21133843

miRNA*: a passenger stranded in RNA-induced silencing complex?

S M Mah1, C Buske, R K Humphries, F Kuchenbauer.   

Abstract

Processing of the pre-microRNA (pre-miRNA) through Dicer1 generates a miRNA duplex, consisting of a miRNA and miRNA* strand (also termed guide strand and passenger strand, respectively). Despite the general consensus that miRNA*s have no regulatory activity, recent publications have provided evidence that the abundance, possible function, and physiological relevance of miRNA*s have been underestimated. This review provides an account of our current understanding of miRNA* origination and activity, mounting evidence for their unique functions and regulatory mechanisms, and examples of specific miRNA*s from the literature.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21133843     DOI： 10.1615/critreveukargeneexpr.v20.i2.40

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN： 1045-4403            Impact factor:   1.807


  38 in total

1.  Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs.

Authors:  Christine Voellenkle; Jeroen van Rooij; Alessandro Guffanti; Elena Brini; Pasquale Fasanaro; Eleonora Isaia; Larry Croft; Matei David; Maurizio C Capogrossi; Anna Moles; Armando Felsani; Fabio Martelli
Journal:  RNA       Date:  2012-01-26       Impact factor: 4.942

Review 2.  MicroRNA control of high-density lipoprotein metabolism and function.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

3.  Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.

Authors:  Sanjay Singh
Journal:  Bioimpacts       Date:  2013-01-14

Review 4.  A big role for small RNAs in HDL homeostasis.

Authors:  Mireille Ouimet; Kathryn J Moore
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

5.  Plasma miR-187* is a potential biomarker for oral carcinoma.

Authors:  Chung-Ji Liu; Jiun-Sheng Lin; Hui-Wen Cheng; Ya-Hui Hsu; Chieh-Yuan Cheng; Shu-Chun Lin
Journal:  Clin Oral Investig       Date:  2016-06-20       Impact factor: 3.573

6.  A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.

Authors:  Leigh Goedeke; Frances M Vales-Lara; Michael Fenstermaker; Daniel Cirera-Salinas; Aranzazu Chamorro-Jorganes; Cristina M Ramírez; Julie A Mattison; Rafael de Cabo; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Mol Cell Biol       Date:  2013-04-01       Impact factor: 4.272

Review 7.  Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline.

Authors:  Elizabeth J Hennessy; Kathryn J Moore
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

8.  Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.

Authors:  Sho Sugawara; Yasutaka Yamada; Takayuki Arai; Atsushi Okato; Tetsuya Idichi; Mayuko Kato; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2018-03-14       Impact factor: 3.172

9.  Experimental evidences for miR-30b as a negative regulator of FOXO3 upregulated by kynurenine.

Authors:  Zhi-Qing Duan; Yan Li; Lu Li
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

10.  Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).

Authors:  Lia Furlaneto Marega; Marcelo Ananias Teocchi; Maria Marluce Dos Santos Vilela
Journal:  Clin Exp Immunol       Date:  2016-05-24       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.